SFX by Ex Libris Inc.

Title:	Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis
Source:	Science [0036-8075] Sherman, D R yr:1996

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	McKinney, J D D. "Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase." Nature 406.6797 (2000): 735-8.
description	2.	Wood, Zachary A A. "Structure, mechanism and regulation of peroxiredoxins." Trends in biochemical sciences 28.1 (2002): 32-40.
description	3.	Gillespie, H. "The biological cost of antimicrobial resistance." Trends in microbiology 5.9 (1997): 337-339.
description	4.	Maisnier-Patin, S. "Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution." Research in microbiology 155.5 (2004): 360-369.
description	5.	BANERJEE, A. "INHA, A GENE ENCODING A TARGET FOR ISONIAZID AND ETHIONAMIDE IN MYCOBACTERIUM-TUBERCULOSIS." Science 263.5144 (1994): 227-230.
description	6.	Muñoz-Elías, Ernesto J J. "Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence." Nature medicine 11.6 (2005): 638-44.
description	7.	Wood, Zachary A A. "Dimers to doughnuts: redox-sensitive oligomerization of 2-cysteine peroxiredoxins." Biochemistry 41.17 (2002): 5493-504.
description	8.	Delaine, T. "Development of isoniazid-NAD truncated adducts embedding a lipophilic fragment as potential bi-substrate InhA inhibitors and antimycobacterial agents." European journal of medicinal chemistry 45.10 (2010): 4554-4561.
description	9.	Dessen, A. "Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis." Science 267.5204 (1995): 1638-1641.
description	10.	Vilcheze, C. "Altered NADH/NAD(+) ratio mediates coresistance to isoniazid and ethionamide in mycobacteria." Antimicrobial agents and chemotherapy 49.2 (2005): 708-720.
description	11.	Muñoz-Elías, Ernesto J J. "Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence." Molecular microbiology 60.5 (2006): 1109-22.
description	12.	Taddeo, B. "Reversion of a human immunodeficiency virus type 1 integrase mutant at a second site restores enzyme function and virus infectivity." Journal of virology 70.12 (1996): 8277-8284.
description	13.	Williams, GC. "The Quarterly Review." The Quarterly review of biology 66.1 (1991): 1-.
description	14.	Batt, L. "Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae." Antimicrobial agents and chemotherapy 47.9 (2003): 2765-9.
description	15.	Mokrousov, I. "Evolution of drug resistance in different sublineages of Mycobacterium tuberculosis Beijing genotype." Antimicrobial agents and chemotherapy 50.8 (2006): 2820-3.
description	16.	Cao, Z. "Bovine mitochondrial peroxiredoxin III forms a two-ring catenane." Structure 13.11 (2005): 1661-1664.
description	17.	McMurry, LM. "Genetic Evidence that InhA of Mycobacterium smegmatis Is a Target for Triclosan." Antimicrobial agents and chemotherapy 43.3 (1999): 711-713.
description	18.	van Kooyk, Y. "DC-SIGN: escape mechanism for pathogens." Nature reviews. Immunology 3.9 (2003): 697-709.
description	19.	Cole, S T T. "Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence." Nature 393.6685 (1998): 537-544.
description	20.	OHTA, T. "THE NEARLY NEUTRAL THEORY OF MOLECULAR EVOLUTION." Annual review of ecology and systematics 23.1 (1992): 263-286.